Estimate Recalculated Nov 11, 2024 01:52PM EST
Charles N York II has an estimated net worth of $6.1 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., and Aeglea BioTherapeutics, Inc..
Charles N York II's CIK is 0001655962
2024 was Charles N York II's most active year for acquiring shares with 11 total transactions. Charles N York II's most active month to acquire stocks was the month of January. 2022 was Charles N York II's most active year for disposing of shares, totalling 16 transactions. Charles N York II's most active month to dispose stocks was the month of April. 2017 saw Charles N York II paying a total of $108,248.94 for 172,459 shares, this is the most they've acquired in one year. In 2024 Charles N York II cashed out on 99,185 shares for a total of $1,201,712.11, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!